Denmark· DK-28107288824

Waskyra

A other hematological agents product containing autologe cd34+ celler m. retrovir. vektor, denosindeaminase (ada)-cdna-sekv./hum. hæmatopoieti.stamc, registered in Denmark by Fondazione Telethon Ets. The same ATC class is registered in 4 of our 19 countries.

ATC B06

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedWaskyraATCB06REGISTER NO.DK-28107288824PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Autologe cd34+ celler m. retrovir. vektor, denosindeaminase (ada)-cdna-sekv./hum. hæmatopoieti.stamc is registered in 4 of 19 countries.

Countries holding a registration under ATC B06 (other hematological agents), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 1 of them publish a price we can compare per daily dose

Autologe cd34+ celler m. retrovir. vektor, denosindeaminase (ada)-cdna-sekv./hum. hæmatopoieti.stamc · ATC B06

4 / 19 countries

  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
autologe CD34+ celler m. retrovir. vektor, denosindeaminase (ADA)-cDNA-sekv./hum. hæmatopoieti.stamc
Manufacturer
Fondazione Telethon Ets
Country
Denmark (DK)
ATC code
B06
ATC class
OTHER HEMATOLOGICAL AGENTS
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28107288824

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/00cb79e3-52d4-4218-9f4f-b67acd145a19
GET /v1/drugs/00cb79e3-52d4-4218-9f4f-b67acd145a19?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "infusionsvæske, dispersion",
  "source": "dkma",
  "strength": "2-10 x 10^6 cells/ml",
  "auth_role": "MOD",
  "dk_drugid": "28107288824",
  "substance": "autologe CD34+ celler m. retrovir. vektor, denosindeaminase (ADA)-cDNA-sekv./hum. hæmatopoieti.stamc",
  "auth_procedure": "Central",
  "in_medicinpriser": false,
  "registration_date_serial": "46031"
}

See everything about autologe cd34+ celler m. retrovir. vektor, denosindeaminase (ada)-cdna-sekv./hum. hæmatopoieti.stamc.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.